Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
Proactive Pregnancy Planning and Reproductive Care in MS
Riley Bove, MD, MMSc
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Aaron Miller, MD
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Updates in MS Care: Key Topics at AAN 2026
Challenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD
Stephen Marder, MD
Nutrition and the Gut-Brain Connection in Schizophrenia
Deanna L. Kelly, PharmD, BCPP
Emerging Serum microRNAs as Early Signals in MS
The Social Brain in Schizophrenia
Michael Green, PhD
Depression as a Signal of MS Progression
Addressing Social and Systemic Barriers in Schizophrenia
Margaret Emerson, DNP, APRN, PMHNP-BC
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
Family Planning in Patients with Multiple Sclerosis
Strengthening Global Infrastructure for FSHD Trials
Marlene Mimi Maeusli, PhD.
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.